(2E)-2-Benzylidene-4,7-dimethyl-2,3-dihydro-1H-inden-1-one (MLT-401), a novel arylidene indanone derivative, scavenges free radicals and exhibits antiproliferative activity of Jurkat cells

[1]Hoake JB, Pastorino JG. Ethanol, oxidative stress and cytokine-induced liver cell injury. Alcohol. 2002; 27:63–8.HoakeJBPastorinoJGEthanol, oxidative stress and cytokine-induced liver cell injuryAlcohol20022763810.1016/S0741-8329(02)00215-XSearch in Google Scholar

[2]Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, Dhama K. Oxidative stress, prooxidants, and antioxidants: the interplay. BioMed Res Int. 2014; 761264. doi:10.1155/2014/761264RahalAKumarASinghVYadavBTiwariRChakrabortySDhamaKOxidative stress, prooxidants, and antioxidants: the interplayBioMed Res Int201476126410.1155/2014/761264392090924587990Open DOISearch in Google Scholar

[3]Gillet JP, Gottesman MM. Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 2010; 596:47–76.GilletJPGottesmanMMMechanisms of multidrug resistance in cancerMethods Mol Biol2010596477610.1007/978-1-60761-416-6_419949920Search in Google Scholar

[4]Schmitz KJ, Otterbach F, Callies R, Levkau B, Hölscher M, Hoffmann O, et al. Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mod Pathol. 2004; 17:15–21.SchmitzKJOtterbachFCalliesRLevkauBHölscherMHoffmannOPrognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 casesMod Pathol200417152110.1038/modpathol.380000214631376Search in Google Scholar

[5]Fodouop SPC, Simo RT, Amvene JM, Talla E, Etet PFS, Takam P, et al. Bioactivity and therapeutic potential of plant extracts in cancer and infectious diseases. J Dis Med Plants. 2015; 1:8–18.FodouopSPCSimoRTAmveneJMTallaEEtetPFSTakamPBioactivity and therapeutic potential of plant extracts in cancer and infectious diseasesJ Dis Med Plants20151818Search in Google Scholar

[6]Özdemir A, Turan-Zitouni G, Kaplancikli ZA, Tunali Y. Synthesis and biological activities of new hydrazide derivatives. J Enzyme Inhib Med Chem. 2008; 29:1–13.ÖzdemirATuran-ZitouniGKaplancikliZATunaliYSynthesis and biological activities of new hydrazide derivativesJ Enzyme Inhib Med Chem20082911310.1080/1475636080239971218825530Search in Google Scholar

[7]Kaplancikli ZA, Turan-Zitouni G, Ozdemir A, Teulade J-C. Synthesis and antituberculosis activity of new hydrazide derivatives. Arch Pharm Chem Life Sci. 2008; 20:20–8.KaplancikliZATuran-ZitouniGOzdemirATeuladeJ-CSynthesis and antituberculosis activity of new hydrazide derivativesArch Pharm Chem Life Sci20082020810.1002/ardp.20080004818720343Search in Google Scholar

[8]Geronikaki A, Eleftheriou P, Vicini P, Alam I, Dixit A, Saxena AK. 2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action. J Med Chem. 2008; 51:5221–8.GeronikakiAEleftheriouPViciniPAlamIDixitASaxenaAK2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory actionJ Med Chem2008515221810.1021/jm800430618702480Search in Google Scholar

[9]Abdelrazek FM, Metz P, Kataeva O, Jäger A, El-Mahrouky SF. Synthesis and molluscicidal activity of new chromene and pyrano[2,3-c]pyrazole derivatives. Arch Pharm. 2007; 340:543–8.AbdelrazekFMMetzPKataevaOJägerAEl-MahroukySFSynthesis and molluscicidal activity of new chromene and pyrano[2,3-c]pyrazole derivativesArch Pharm2007340543810.1002/ardp.20070015717912679Search in Google Scholar

[10]Ottanà R, Maccari R, Ciurleo R, Vigorita MG, Panico AM, Cardile V, et al. Synthesis and in vitro evaluation of 5-arylidene-3-hydro-xyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures. Bioorg Med Chem. 2007; 15:7618–25.OttanàRMaccariRCiurleoRVigoritaMGPanicoAMCardileVSynthesis and in vitro evaluation of 5-arylidene-3-hydro-xyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte culturesBioorg Med Chem20071576182510.1016/j.bmc.2007.09.00117889545Search in Google Scholar

[11]da Costa Leite LF, Veras Mourão RH, de Lima Mdo C, Galdino SL, Hernandes MZ, de Assis Rocha Neves F, et al. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities. Eur J Med Chem. 2007; 42:1263–71.da Costa LeiteLFVeras MourãoRHde Lima MdoCGaldinoSLHernandesMZde Assis Rocha NevesFSynthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activitiesEur J Med Chem20074212637110.1016/j.ejmech.2007.02.01517448573Search in Google Scholar

[12]Bansal R, Guleria S. Synthesis of 16E-[3-methoxy-4-(2minoethoxy) benzylidene]androstene derivatives as potent cytotoxic agents. Steroids. 2008; 73:1391–9.BansalRGuleriaSSynthesis of 16E-[3-methoxy-4-(2minoethoxy) benzylidene]androstene derivatives as potent cytotoxic agentsSteroids2008731391910.1016/j.steroids.2008.07.00418694772Search in Google Scholar

[13]Menezes JCJMDS. Arylidene indanone scaffold: medicinal chemistry and structure–activity relationship view. RSC Adv. 2017; 7:9357–72.MenezesJCJMDSArylidene indanone scaffold: medicinal chemistry and structure–activity relationship viewRSC Adv2017793577210.1039/C6RA28613ESearch in Google Scholar

[14]Pati HN, Das U, De Clercq E, Balzarini J, Dimmock JR. Molecular modifications of 2-arylidene-1-indanones leading to increased cytotoxic potencies. J Enzyme Inhib Med Chem. 2007; 22:37–42.PatiHNDasUDe ClercqEBalzariniJDimmockJRMolecular modifications of 2-arylidene-1-indanones leading to increased cytotoxic potenciesJ Enzyme Inhib Med Chem200722374210.1080/1475636060095805717373545Search in Google Scholar

[15]Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004 56:185–229.MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev20045618522910.1124/pr.56.2.615169927Search in Google Scholar

[16]Carrera MP, Ramírez-Expósito MJ, Martínez-Martos JM. Actual and potential agents and biomarkers in the treatment of cancer. Anti-cancer Agents Med Chem. 2009; 9:500–16.CarreraMPRamírez-ExpósitoMJMartínez-MartosJMActual and potential agents and biomarkers in the treatment of cancerAnti-cancer Agents Med Chem200995001610.2174/18715200978845182419519292Search in Google Scholar

[17]Rajagopalan P, Alahmari KA, Elbessoumy AA, Balasubramaniam M, Suresh R, Shariff MEA, Chandramoorthy HC. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer. Cancer Chemother Pharmacol. 2016; 77:393–404.RajagopalanPAlahmariKAElbessoumyAABalasubramaniamMSureshRShariffMEAChandramoorthyHCBiological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancerCancer Chemother Pharmacol20167739340410.1007/s00280-015-2956-826781309Search in Google Scholar

[18]Becker K, Schroecksnadel S, Gostner J, Zaknun C, Schennach H, Überall F, Fuchs D. Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds. Phytomedicine. 2014; 21:164–71.BeckerKSchroecksnadelSGostnerJZaknunCSchennachHÜberallFFuchsDComparison of in vitro tests for antioxidant and immunomodulatory capacities of compoundsPhytomedicine2014211647110.1016/j.phymed.2013.08.00824041614Search in Google Scholar

[19]Moon JK, Shibamoto T. Antioxidant assays for plant and food components. J Agric Food Chem. 2009; 57:1655–66.MoonJKShibamotoTAntioxidant assays for plant and food componentsJ Agric Food Chem20095716556610.1021/jf803537k19182948Search in Google Scholar

[20]Lee HJ, Kim TH, Kim JN. One-pot synthesis of (E)-2-arylideneindan-1-ones from the Baylis-Hillman adducts via the successive inter- and intramolecular Friedel-Crafts reactions. Bull Korean Chem Soc. 2001; 22:1059–68.LeeHJKimTHKimJNOne-pot synthesis of (E)-2-arylideneindan-1-ones from the Baylis-Hillman adducts via the successive inter- and intramolecular Friedel-Crafts reactionsBull Korean Chem Soc20012210596810.1002/chin.200216119Search in Google Scholar

[21]Prasanna R, Harish CC. Anticancer effect of a novel 2-arylidene-4,7-dimethyl indan-1-one against human breast adenocarcinoma cell line by G₂/M cell cycle arrest. Oncology Res. 2010; 18:461–8.PrasannaRHarishCCAnticancer effect of a novel 2-arylidene-4,7-dimethyl indan-1-one against human breast adenocarcinoma cell line by G₂/M cell cycle arrestOncology Res201018461810.3727/096504010X1270491612474720681405Search in Google Scholar

[22]Dzoyem JP, Eloff JN. Anti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South Africa. J Ethnopharmacol. 2015; 160:194–201.DzoyemJPEloffJNAnti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South AfricaJ Ethnopharmacol201516019420110.1016/j.jep.2014.11.034Search in Google Scholar

[23]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55–63.MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods198365556310.1016/0022-1759(83)90303-4Search in Google Scholar

[24]Solomson LP, Liepkalns VA, Spector A. Changes in (Na⁺ + K⁺)-ATPase activity of Ehrlich ascites tumor cells produced by alteration of fatty acid composition. Biochem. 1976; 15:892–7.SolomsonLPLiepkalnsVASpectorAChanges in (Na⁺ + K⁺)-ATPase activity of Ehrlich ascites tumor cells produced by alteration of fatty acid compositionBiochem197615892710.1021/bi00649a026Search in Google Scholar

[25]Hjertén S, Pan H. Purification and characterization of two forms of a low-affinity Ca²⁺-ATPase from erythrocyte membranes. Biochem Biophys Acta. 1983; 728:281–8.HjerténSPanHPurification and characterization of two forms of a low-affinity Ca²⁺-ATPase from erythrocyte membranesBiochem Biophys Acta1983728281810.1016/0005-2736(83)90480-7Search in Google Scholar

[26]White MD and Ralston GB. Purification of water soluble Mg²⁺ ATPase from human erythrocyte membranes. Biochem Biophys Acta. 1980; 599:569–79.WhiteMDRalstonGBPurification of water soluble Mg²⁺ ATPase from human erythrocyte membranesBiochem Biophys Acta19805995697910.1016/0005-2736(80)90200-XSearch in Google Scholar

[27]Deng M, Zha J, Jiang Z, Jia X, Shi Y, Li P, et al. Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia. J Transl Med. 2018; 16:47. doi:10.1186/s12967-018-1421-yDengMZhaJJiangZJiaXShiYLiPApatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemiaJ Transl Med2018164710.1186/s12967-018-1421-y583185229490645Open DOISearch in Google Scholar

[28]Guo J, Zhang Y, Zhang J, Liang J, Zeng L, Guo G. Anticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line. Chem Biol Interact. 2012; 199:38–48.GuoJZhangYZhangJLiangJZengLGuoGAnticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell lineChem Biol Interact2012199384810.1016/j.cbi.2012.06.00122704995Search in Google Scholar

[29]Kamal A, Hussaini SMA, Malik MS. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers. Anticancer Agents Med Chem. 2015; 15:565–74.KamalAHussainiSMAMalikMSRecent developments towards podophyllotoxin congeners as potential apoptosis inducersAnticancer Agents Med Chem2015155657410.2174/187152061466614113012562325469512Search in Google Scholar

[30]Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet. 2009; 43:95–118.WangCYouleRJThe role of mitochondria in apoptosisAnnu Rev Genet2009439511810.1146/annurev-genet-102108-134850476202919659442Search in Google Scholar

[31]Majtnerová P, Roušar T. An overview of apoptosis assays detecting DNA fragmentation. Mol Biol Rep. 2018; 45:1469–78.MajtnerováPRoušarTAn overview of apoptosis assays detecting DNA fragmentationMol Biol Rep20184514697810.1007/s11033-018-4258-930022463Search in Google Scholar

[32]Babes RM, Tofolean IT, Sandu RG, Baran OE, Cosoreanu V, Ilie MT, et al. Simple discrimination of sub-cycling cells by propidium iodide flow cytometric assay in Jurkat cell samples with extensive DNA fragmentation. Cell Cycle. 2018; 17:766–79.BabesRMTofoleanITSanduRGBaranOECosoreanuVIlieMTSimple discrimination of sub-cycling cells by propidium iodide flow cytometric assay in Jurkat cell samples with extensive DNA fragmentationCell Cycle2018177667910.1080/15384101.2018.1426415Search in Google Scholar

[33]Lopez J, Tait SW. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer. 2015; 112:957–62.LopezJTaitSWMitochondrial apoptosis: killing cancer using the enemy withinBr J Cancer20151129576210.1038/bjc.2015.85Search in Google Scholar

[34]Gassbarini A, Borle AB, Faghali H, Bender C, Francavilla A, Van Thiel D. Effect of anoxia on intracellular ATP, Na⁺_i, Ca²⁺_i, Mg²⁺_i, and cytotoxicity in rat hepatocytes. J Biol Chem. 1994; 267: 6654–63.GassbariniABorleABFaghaliHBenderCFrancavillaAVan ThielDEffect of anoxia on intracellular ATP, Na⁺_i, Ca²⁺_i, Mg²⁺_i, and cytotoxicity in rat hepatocytesJ Biol Chem199426766546310.1016/S0021-9258(19)50477-XSearch in Google Scholar